(Q40731786)

23 September 2017

title

Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva (English)

1 reference

23 September 2017

Jan G M Bolscher

1

1 reference

23 September 2017

Kamran Nazmi

2

1 reference

23 September 2017

Leonie J Ran

3

1 reference

23 September 2017

Frank A C van Engelenburg

4

1 reference

23 September 2017

Hanneke Schuitemaker

5

1 reference

23 September 2017

Enno C I Veerman

6

1 reference

23 September 2017

Arie V Nieuw Amerongen

7

1 reference

23 September 2017

publication date

1 April 2002

1 reference

European Journal of Oral Sciences

23 September 2017

published in

1 reference

23 September 2017

volume

110

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

149-156

1 reference

HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Detection of proviral sequences in saliva of patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Components of saliva inactivate human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Saliva inhibits HIV-1 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

In vitro inhibition of HIV-1 infectivity by human salivas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Human Submandibular Saliva Aggregates HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Immunochemical analysis of high molecular-weight human salivary mucins (MG1) using monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Distinct populations of high-Mr mucins secreted by different human salivary glands discriminated by density-gradient electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Strong ionic interactions between mucins and two basic proteins, mucus proteinase inhibitor and lysozyme, in human bronchial secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

Recovery of infectious HIV-1 from whole saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

HIV recovery from saliva before and after dental treatment: inhibitors may have critical role in viral inactivation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

Human glandular salivas: their separate collection and analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

A monoclonal antibody directed against high M(r) salivary mucins recognizes the SO3-3Gal beta 1-3GlcNAc moiety of sulfo-Lewis(a): a histochemical survey of human and rat tissue

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

Detection and quantification of MUC7 in submandibular, sublingual, palatine, and labial saliva by anti-peptide antiserum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

A role for Lewis a antigens on salivary agglutinin in binding to Streptococcus mutans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

The other side of scavenger receptors: pattern recognition for host defense.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

Defensins inhibit HIV replication in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2002.11175.X

7 January 2021

10.1034/J.1600-0722.2002.11175.X

Identifiers

DOI

1 reference

23 September 2017

1 reference